Related Experiment Videos

Topical glucocorticoid therapy in dermatology

W Sterry¹, K Asadullah

¹Department of Dermatoloy, University Hospital Charité, Humboldt University, Schumannstr. 20-21, 10117 Berlin, Germany. wolfram.sterry@charite.de

Ernst Schering Research Foundation Workshop

|October 3, 2002

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

Tinea capitis in Germany. A survey in 1998.

Mycoses·2017

Dose-escalation study evaluating pegylated interferon alpha-2a in patients with cutaneous T-cell lymphoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017

Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa/hidradenitis suppurativa.

The British journal of dermatology·2017

See all related articles